Chuan‐Ming Hao

机构：Fudan University, ProQuest (United States), Huashan Hospital · ORCID：0000-0002-4307-0987

发表论文 285 篇 · 总被引 13351 次 · h-index 58

代表论文

• Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 41)
• Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy (2024 · Nephrology Dialysis Transplantation · 被引 35)
• Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China (2024 · Renal Failure · 被引 14)
• Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic (2024 · Clinical Kidney Journal · 被引 10)
• Multimodal analysis stratifies genetic susceptibility and reveals the pathogenic mechanism of kidney injury in diabetic nephropathy (2025 · Cell Reports Medicine · 被引 6)
• Executive Summary of the Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update (2025 · Nephrology · 被引 6)